(Date:11/23/2009)...re-FirstCall/--PDLBioPharma,Inc.(PDL)(Nasdaq: PDLI...,2009astheex-dividenddateforits$200millionspeciald...ntransactioncompletedonNovember2,2009.Thedividendw...dontherecorddate,December1,2009.NASDAQhassettheapp...ofcommonstockforpurposesoftheex-dividenddateonNove...
(Date:11/23/2009)...stCall/--NeogenCorporation(Nasdaq: NEOG )announced...,sBoardofDirectorsatthecompany,srecentannualmeetin...experienceinthefood,agriculture,andtradeindustries...aleconomicsatVirginiaTechUniversity.FromJanuary200...renegotiatorwiththerankofambassador. ,, "Sinceo...
(Date:11/23/2009)...esignC or p.(IDC)announcedtodaythatDr.BruceL.A.Car...ccessfultrackrec or dinbiotechnologyexecutivemanag...enetics,inSeattle,WAandChiefScientificOfficeratNov...//www.newscom.com/cgi-bin/prnh/20091123/SF15228 ) ...fficercommented,"IamdelightedtowelcomeDr.BruceCart...
(Date:11/23/2009)...re/--Frost&Sullivan,theGrowthPartnershipCompan...shipandinnovationThursday,November19,2009attheExce...Antonio,Texas. ,, (Logo: http://www.newscom.com...eInnovationAwardsaregiventocompaniesthathavemadeas...healthcare.Suchcompanieshaveshownsuccessatmeetingt...
Breaking Biology Technology:PDL BioPharma Announces Ex-Dividend Date of November 27 for Special Dividend 2Richard T. Crowder Joins Neogen's Board of Directors 2Immune Design Corp. Announces Appointment of Dr. Bruce L.A. Carter as Executive Chairman and Director 2Excellence in Healthcare Innovation Recognized by Frost & Sullivan 2Excellence in Healthcare Innovation Recognized by Frost & Sullivan 3...Dr. DAVID HARDY, TO DISCUSS CLINICAL USE OF THE, T...WITH THE THIRD QUARTER 2008 FINANC... Calif., Oct. 23 Monogram,Biosciences, Inc., (Nas...nce,call on Monday, October 27, 2008 at 4:30 p.m. ...gram,s Trofile(TM) Assay in conjunction with Pfize...
...echne Corporation,(Nasdaq: TECH ) announced today...dividend of $0.25 per share for the quarter ended ... payable November 17, 2008 to all common,sharehold...nd, Techne Corporation,s Chairman and Chief Execut...that the Board has decided to,pay this dividend. A...
...swire-FirstCall/ - Oncolytics Biotech Inc. (TSX:,O... entitled "Phase I Trial,of Oncolytic Reovirus (RE...xel in Patients with Advanced Solid Cancers" will ... Journal of Immunotherapy,the official journal of ...f,Cancer (iSBTc). The principal investigator for t...
Other Biology Technology:Monogram Announces Conference Call 2Oncolytics Biotech Inc. Collaborators to Present Combination REOLYSIN(R) and Paclitaxel/Carboplatin Results at iSBTc Annual Meeting 2Oncolytics Biotech Inc. Collaborators to Present Combination REOLYSIN(R) and Paclitaxel/Carboplatin Results at iSBTc Annual Meeting 3Pronase Reagent from Biomeda Corporation
Sheep Anti-Pig Malate Dehydrogenase Polyclonal Antibody, Unconjugated from Abcam
Mouse Anti-Human HAMP Polyclonal Antibody, Unconjugated from ABR-Affinity BioReagents
Rabbit Anti-Human TAP2 Polyclonal Antibody, Unconjugated from Atlas Antibodies
Biology Products: